• Title of article

    Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL

  • Author/Authors

    Luis and Martيnez-Lorenzo، نويسنده , , Marيa José and Anel، نويسنده , , Alberto and Saez-Gutierrez، نويسنده , , Berta and Royo-Caٌas، نويسنده , , Marيa and Bosque، نويسنده , , Alberto and Alava، نويسنده , , Marيa Angeles and Piٌeiro، نويسنده , , Andrés and Lasierra، نويسنده , , Pilar and Asيn-Ungrيa، نويسنده , , Jaime and Larrad، نويسنده , , Luis، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2007
  • Pages
    13
  • From page
    28
  • To page
    40
  • Abstract
    The infiltration and accumulation of T cells in the rheumatoid arthritis (RA) synovial fluid (SF) are hallmarks of disease. We aimed to assess the functional relevance of FasL and of APO2L/TRAIL in the persistence of T cells in the rheumatoid SF. We have analyzed the expression of the activation markers HLA-DR and CD69 and also of the death receptor Fas/CD95 and death ligands FasL or APO2L/TRAIL in CD3+ lymphocytes from SF of 62 RA patients, together with their sensitivity to anti-Fas mAb or to rAPO2L/TRAIL, using as controls T lymphocytes present in SF of 20 patients with traumatic arthritis. T lymphocytes infiltrated in SF of RA patients have a chronically activated phenotype, but they are resistant to Fas-induced toxicity. However, they are more susceptible to rAPO2L/TRAIL than T cells in the SF of traumatic arthritis patients. In addition, we found very low amounts of bioactive FasL and APO2L/TRAIL associated with exosomes in SF from RA patients as compared with SF from traumatic arthritis patients. The observation on the sensitivity of RA SF T cells to rAPO2L could have therapeutic implications because bioactive APO2L/TRAIL could be beneficial as a RA treatment.
  • Keywords
    T lymphocytes , rheumatoid arthritis , TOLERANCE , human , apoptosis
  • Journal title
    Clinical Immunology
  • Serial Year
    2007
  • Journal title
    Clinical Immunology
  • Record number

    1852040